In a significant policy shift, former President Donald Trump signed an executive order aimed at accelerating the reclassification of marijuana under the US Controlled Substances Act. For decades, marijuana has been classified as a Schedule I drug, denoting a high potential for abuse and no accepted medical use—categorizing it alongside substances like heroin. This classification has long posed challenges for medical research, limiting studies into the plant’s potential therapeutic benefits.
The executive order directs the Department of Justice to expedite the ongoing administrative process necessary for reclassification. While the order itself does not immediately change marijuana’s legal status, it emphasizes a swift resolution according to federal law guidelines. This action follows activism and policy proposals from various sectors to reconsider marijuana’s legal status in light of contemporary scientific understanding and shifting public opinion.
In 2023, the Department of Health and Human Services recommended rescheduling marijuana to Schedule III, reflecting a recognition of its medical utility and reduced abuse risk. Alongside, the Justice Department issued a proposed rule in May 2024, drawing approximately 43,000 public comments, with overwhelming support for more lenient policies regarding marijuana. With recreational use legalized in 24 states and medical applications approved in 40 states and the District of Columbia, the current federal stance appears increasingly out of step with state-level legislation.
Former President Joe Biden had previously initiated the reevaluation process in 2022, encouraging an expedited review of marijuana’s Schedule I classification. His administration pointed to the discrepancies in how substances like fentanyl and methamphetamine—which have driven overdose epidemics—are classified less stringently than marijuana. Despite these inconsistencies, nationwide regulatory changes remain complex and procedurally meticulous.
Trump’s directive underscores a broader national dialogue on drug policy, particularly as daily use of marijuana among adults surpasses that of alcohol. This executive action reflects a potential pivot towards reforms that could harmonize federal statutes with the liberalizing trend of state laws. With the current momentum, administrative procedures may soon align marijuana’s legal framework with its practical status across much of the United States. More details on the executive order can be accessed at JURIST.